RESPONSE - 3958 ads
Saturday, June 28, 2025
Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Thursday, June 26, 2025
Selank is a synthetic derivative of the tetrapeptide tuftsin that contains a proline-glycine-proline sequence at the C-terminus and has anxiolytic and anti-inflammatory activities. It increases the amplitude and discharge rate of inhibitory postsynaptic currents of neurons in the...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Wednesday, June 25, 2025
PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Tuesday, June 24, 2025
As a common organic synthesis intermediate, trans-1,4-cyclohexanediamine is mainly used as a molecular skeleton for structural modification and synthesis of drug molecules, such as integrated stress response inhibitors related to the unfolded protein response (UPR) caused by the accumulation...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +15 2 82 60 18 74
Tuesday, June 24, 2025
Thymalfasin is a protein and peptide hormone produced by the superficial cortex and medullary epithelial cells of the thymus with immune-enhancing function, it is an acidic peptide consisting of 28 amino acids, it is a kind of biological response modifier, with a wide range of biological...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Saturday, June 21, 2025
Lacosamide is a novel NMDA receptor glycine site binding antagonist, belonging to a new class of functional amino acids, and an anticonvulsant drug with a new dual mechanism of action. It can selectively promote the slow inactivation of sodium channels and regulate collapse response...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +15 2 82 60 18 74





